Cleveland Clinic – Mastering the Management of Aortic Valve Disease 2025 (Videos)
Advanced Cardiology Course on Aortic Stenosis, TAVR, SAVR & Structural Heart Interventions
Overview
Cleveland Clinic – Mastering the Management of Aortic Valve Disease 2025 is a comprehensive, evidence-based cardiovascular education program designed to provide clinicians with the latest advances in the diagnosis, imaging, risk stratification, and treatment of aortic valve disease. Developed by internationally recognized experts from Cleveland Clinic, this course delivers an in-depth review of modern valvular heart disease management with a particular focus on Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), multimodality cardiac imaging, and patient-centered decision-making.
Featuring 50 expert-led video sessions, the program explores contemporary approaches to aortic stenosis, aortic regurgitation, bicuspid aortic valve disease, valve durability, procedural complications, and emerging structural heart interventions. Participants gain practical insights into integrating evidence-based guidelines, advanced imaging techniques, and multidisciplinary heart team strategies into daily clinical practice.
Whether preparing for board examinations, updating clinical knowledge, or refining advanced valvular heart disease management skills, this course provides a comprehensive resource for cardiovascular professionals seeking excellence in structural heart care.
Course Specifications
- Format: On-Demand Video Course
- Content: 50 Expert-Led Video Sessions
- Release Date: December 2025
- Level: Intermediate to Advanced
- Institution: Cleveland Clinic
- Focus: Aortic Valve Disease, TAVR, SAVR, Imaging & Structural Heart Interventions
Course Overview
Aortic valve disease remains one of the most common and clinically significant cardiovascular disorders worldwide. Advances in transcatheter therapies, surgical techniques, and multimodality imaging have transformed treatment options and improved outcomes for patients with both simple and complex valvular disease.
This course provides a comprehensive review of modern aortic valve disease management, emphasizing:
- Contemporary guideline-based care
- Structural heart interventions
- Advanced cardiac imaging
- Risk assessment and patient selection
- Procedural planning and complication management
- Long-term follow-up and valve durability
Participants learn how to optimize treatment decisions through a multidisciplinary heart team approach while applying the latest clinical evidence and technological innovations.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Diagnose and classify various forms of aortic valve disease.
- Apply current guidelines for timing and selection of valve interventions.
- Evaluate patients for TAVR and SAVR using evidence-based criteria.
- Utilize multimodality imaging for diagnosis, procedural planning, and follow-up.
- Manage complications associated with transcatheter and surgical interventions.
- Assess valve durability and long-term outcomes.
- Develop treatment strategies for complex valvular heart disease.
- Integrate contemporary clinical trial data into patient management.
- Improve outcomes through multidisciplinary heart team collaboration.
Major Topics Covered
Aortic Valve Disease Fundamentals
Clinical Evaluation
- Aortic stenosis pathophysiology
- Aortic regurgitation mechanisms
- Symptom assessment
- Risk stratification strategies
Patient Selection
- Timing of intervention
- Shared decision-making
- Management of elderly and high-risk patients
Transcatheter Aortic Valve Replacement (TAVR)
Contemporary TAVR Practice
- Patient selection criteria
- Procedural planning
- Device selection
Advanced TAVR Topics
- Valve-in-valve procedures
- TAVR in bicuspid valves
- Expanding indications
Clinical Outcomes
- Short- and long-term results
- Quality of life improvements
- Future directions in TAVR
Surgical Aortic Valve Replacement (SAVR)
Surgical Management
- Conventional SAVR
- Minimally invasive approaches
- Prosthetic valve selection
Complex Surgical Cases
- Redo valve surgery
- Combined valve and aortic procedures
- Root replacement techniques
Multimodality Cardiac Imaging
Echocardiography
- Transthoracic echocardiography (TTE)
- Transesophageal echocardiography (TEE)
- Hemodynamic assessment
Cardiac CT
- Annular sizing
- Coronary assessment
- Procedural planning
Cardiac MRI
- Ventricular function assessment
- Myocardial characterization
- Advanced valvular evaluation
Imaging-Guided Decision Making
- Aortic calcium scoring
- Flow assessment
- Structural heart intervention planning
Aortic Stenosis
Contemporary Management
- Severe aortic stenosis
- Low-flow, low-gradient AS
- Asymptomatic severe AS
Heart Failure & Aortic Stenosis
- Ventricular remodeling
- Heart failure management
- Advanced heart failure considerations
Aortic Regurgitation
Diagnostic Evaluation
- Severity assessment
- Ventricular adaptation
- Imaging findings
Treatment Strategies
- Medical management
- Surgical intervention
- Emerging transcatheter therapies
Bicuspid Aortic Valve Disease
Congenital Valve Disorders
- Bicuspid valve morphology
- Associated aortopathy
- Genetic considerations
Long-Term Management
- Surveillance strategies
- Intervention timing
- Family screening recommendations
Procedural Complications & Critical Care
TAVR Complications
- Hemodynamic collapse
- Coronary obstruction
- Vascular complications
Conduction Abnormalities
- Pacemaker dependency
- Conduction system injury
- Post-procedure monitoring
Paravalvular Leak
- Diagnosis
- Prevention
- Treatment strategies
Cardiogenic Shock
- Recognition and management
- Mechanical circulatory support
- Critical care considerations
Endocarditis & Valve Infection
Infective Endocarditis
- Diagnostic strategies
- Imaging evaluation
- Surgical management
Prosthetic Valve Infection
- Risk factors
- Therapeutic approaches
- Long-term outcomes
Antithrombotic Therapy
Post-TAVR Management
- Antiplatelet therapy
- Anticoagulation strategies
- Bleeding risk assessment
Evidence-Based Recommendations
- Guideline updates
- Personalized treatment planning
Valve Durability & Clinical Trials
Long-Term Outcomes
- Prosthetic valve durability
- Structural valve degeneration
- Reintervention strategies
Landmark Clinical Trials
- Recent TAVR studies
- Surgical outcomes research
- Future therapeutic directions
Educational Features
✔ 50 expert-led video lectures
✔ Comprehensive aortic valve disease curriculum
✔ TAVR and SAVR education
✔ Multimodality imaging review
✔ Structural heart intervention updates
✔ Evidence-based guideline integration
✔ Clinical trial reviews
✔ Complication management strategies
✔ Heart team decision-making principles
✔ Board-review level educational content
Who Should Attend?
This course is ideal for:
- Cardiologists
- Interventional Cardiologists
- Structural Heart Specialists
- Cardiology Fellows
- Cardiothoracic Surgeons
- Cardiac Anesthesiologists
- Heart Failure Specialists
- Internal Medicine Physicians
- Critical Care Physicians
- Nurse Practitioners
- Physician Assistants
- Advanced Practice Providers involved in cardiovascular care
Why This Course Stands Out
✔ Developed by Cleveland Clinic structural heart experts
✔ Comprehensive review of aortic valve disease
✔ Strong emphasis on TAVR and SAVR decision-making
✔ Advanced multimodality imaging education
✔ Focus on real-world clinical application
✔ Covers both foundational and advanced concepts
✔ Reviews latest guidelines and clinical trials
✔ Excellent resource for board preparation
✔ Practical management of complex valvular cases
✔ Designed to improve patient outcomes and procedural success
Product Details
Course: Cleveland Clinic – Mastering the Management of Aortic Valve Disease 2025
Format: 50 Video Lectures
Release Date: December 2025
Level: Intermediate to Advanced
Educational Focus: Aortic Valve Disease, TAVR, SAVR, Structural Heart Interventions & Cardiac Imaging
| S. No. | Title | Duration |
|---|---|---|
| 1 | Aortic Valve Repair & Root Reimplantation | 16:03 |
| 2 | Importance of Prosthesis-Patient Mismatch after TAVR: Definitions, Incidence and Clinical Relevance | 09:18 |
| 3 | Planning for Successful Valve-in-Valve / TAV-in-TAV | 13:56 |
| 4 | Cerebral Embolic Protection During TAVR: What Does Data Support? | 08:16 |
| 5 | Optimal Antithrombotic Therapies Post-TAVR: Updates and Controversies | 12:50 |
| 6 | Management of Hemodynamic Collapse During TAVR | 11:51 |
| 7 | Management of Paravalvular Leaks After SAVR and TAVR | 08:42 |
| 8 | Interventional Techniques and Trials: Preemptive TAVR & Device Durability | 11:14 |
| 9 | Aortic Valve Durability: 5- and 7-Year Results From the COMMENCE Trial | 05:40 |
| 10 | Predictors of Pacemaker Dependency | 10:27 |
| 11 | Case Presentation: Cardiogenic Shock Presenting to CICU | 06:53 |
| 12 | Acute Valvular Emergencies: Assessment and Stabilization in Cardiogenic Shock | 06:36 |
| 13 | Aortic Valve Interventions in Patients in Cardiogenic Shock | 12:09 |
| 14 | Aortic Stenosis and Cardiogenic Shock | 05:24 |
| 15 | Case Presentation: Radiation Heart Disease with Aortic Valve Involvement | 05:50 |
| 16 | Radiation Associated Cardiovascular Disease: Diagnosis and Management | 10:16 |
| 17 | TAVR for Patients with Prior Radiation Therapy | 09:34 |
| 18 | Aortic Valve Disease Associated with Radiation: Surgical Options | 09:03 |
| 19 | Case Presentation: Young Patient With Connective Tissue Disorder (Marfan’s vs LDS) | 06:13 |
| 20 | Screening and Managing High-Risk Patients With Hereditable Thoracic Aortic Disease | 11:49 |
| 21 | Surgical Management of the Aortic Root | 12:19 |
| 22 | Our Most Important Contributions to TAVR from Cleveland Clinic: 2025 | 09:50 |
| 23 | Case Presentation: Patient With Severe Aortic Insufficiency | 06:04 |
| 24 | Aortic Regurgitation: Multimodality Imaging Work-Up and Guidelines | 10:34 |
| 25 | Treatment of Aortic Insufficiency Using TAVR Systems: Current Landscape in 2025 | 10:30 |
| 26 | Most Important TAVR Papers 2024–2025 | 11:50 |
| 27 | The Most Important Surgical CCF Papers | 15:24 |
| 28 | Clinical Information and Management: Beyond the Index Procedure | 10:59 |
| 29 | Medical Therapy for Aortic Stenosis: Emerging Evidence and Practice | 09:46 |
| 30 | Managing Heart Failure in Aortic Stenosis With Multivalve Disease | 11:33 |
| 31 | Aortic Stenosis and Heart Failure | 09:43 |
| 32 | Imaging Cardiologist: Multimodality Imaging in Decision Making | 14:18 |
| 33 | Benefit of Surgical Intervention in Low Flow, Low Gradient Severe AS | 02:06 |
| 34 | Case Presentation: Aortic Valve Endocarditis | 05:05 |
| 35 | Clinical/Imaging Cardiologist: Role of Multimodality Imaging | 10:28 |
| 36 | Critical Care Management in Aortic Endocarditis | 08:26 |
| 37 | Aortic Valve Endocarditis: Surgical Options | 08:48 |
| 38 | Case Presentation: Low Risk Aortic Stenosis | 05:33 |
| 39 | Case Presentation: Low Flow Low Gradient Aortic Stenosis | 06:46 |
| 40 | Case Presentation: Stenotic Bicuspid Aortic Valve in an Octogenarian | 06:41 |
| 41 | Aortic Stenosis in an Octogenarian: Frailty, Imaging, Futility | 10:46 |
| 42 | Association of BAV Anatomy With TAVR Outcomes | 10:05 |
| 43 | Surgeon: Role of Surgery and Contemporary Outcomes | 04:10 |
| 44 | Assessing Flow Reserve, Aortic Calcium Score, Team-Based Care | 12:02 |
| 45 | TAVR for Low-Flow, Low-Gradient Severe AS: State-of-the-Art Review | 11:01 |
| 46 | Surgical Role: Current Data to Justify SAVR | 14:04 |
| 47 | Interventional Role: Data Supporting Low-Risk TAVR Trials | 09:53 |
| 48 | Contemporary Trends in Aortic Valve Disease Management | 10:39 |
| 49 | Sex Differences in Aortic Valve Disease: Why Should We Care? | 12:11 |
| 50 | Evaluation of Procedural Risk: Shared Decision Making | 25:26 |







